Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q3

3034.TEDINET S100Q6EO
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥126.1bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥166.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥124.5bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥6.8bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥6.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥7.1bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥10.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.1bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥7.1bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥7.1bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥4.2bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥105.5bnat 2022-12-31Cons.Assets
Total assets¥96.0bnat 2022-03-31Cons.Assets
Total assets¥103.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥58.3bnat 2022-12-31Cons.Liabilities
Total liabilities¥52.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥47.3bnat 2022-12-31Cons.Net assets
Net assets / equity¥43.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥42.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥26.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥16.7bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥112.572022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.432022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.512021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥113.262021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.262021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio44.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio41.1%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥2.6bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥115.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥115.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥66m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥11.1bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥250m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
—segment totalrevenue2022-04-01 → 2022-12-31¥126.4bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥126.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥317m
—segment totalsegment profit2022-04-01 → 2022-12-31¥9.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥308m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥308m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥2.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2021-04-01 → 2021-12-31¥114.9bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2021-04-01 → 2021-12-31¥114.9bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥46m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2021-04-01 → 2021-12-31¥8.4bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-12-31¥9.9bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-12-31¥9.7bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥261m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-12-31¥930m
—segment totalrevenue2021-04-01 → 2021-12-31¥124.9bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥124.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥308m
—segment totalsegment profit2021-04-01 → 2021-12-31¥9.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 367
ItemContextValueUnit
Treasury stockPrior1YearInstant-3012000000JPY
Treasury stockCurrentQuarterInstant-2669000000JPY
Shareholders equityPrior1YearInstant43849000000JPY
Shareholders equityCurrentQuarterInstant47257000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-14000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-13000000JPY
Valuation and translation adjustmentsPrior1YearInstant-14000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-13000000JPY
Non controlling interestsPrior1YearInstant45000000JPY
Non controlling interestsCurrentQuarterInstant47000000JPY
Net assetsPrior1YearInstant43881000000JPY
Net assetsCurrentQuarterInstant47291000000JPY
Liabilities and net assetsPrior1YearInstant95984000000JPY
Liabilities and net assetsCurrentQuarterInstant105544000000JPY
Net salesPrior1YTDDuration124545000000JPY
Net salesCurrentYTDDuration126101000000JPY
Cost of salesPrior1YTDDuration107634000000JPY
Cost of salesCurrentYTDDuration108961000000JPY
Gross profitPrior1YTDDuration16911000000JPY
Gross profitCurrentYTDDuration17139000000JPY
Selling general and administrative expensesPrior1YTDDuration9989000000JPY
Selling general and administrative expensesCurrentYTDDuration10297000000JPY
Operating incomePrior1YTDDuration6921000000JPY
Operating incomeCurrentYTDDuration6841000000JPY
House rent income noiPrior1YTDDuration26000000JPY
House rent income noiCurrentYTDDuration47000000JPY
Commission fee noiPrior1YTDDuration71000000JPY
Commission fee noiCurrentYTDDuration89000000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration5000000JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration－JPY
Subsidy income noiPrior1YTDDuration17000000JPY
Subsidy income noiCurrentYTDDuration8000000JPY
Guarantee commission received noiPrior1YTDDuration44000000JPY
Guarantee commission received noiCurrentYTDDuration44000000JPY
Cancelation income noiPrior1YTDDuration37000000JPY
Cancelation income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration78000000JPY
Other noiCurrentYTDDuration217000000JPY
Non operating incomePrior1YTDDuration281000000JPY
Non operating incomeCurrentYTDDuration407000000JPY
Interest expenses noePrior1YTDDuration78000000JPY
Interest expenses noeCurrentYTDDuration59000000JPY
Other noePrior1YTDDuration52000000JPY
Other noeCurrentYTDDuration94000000JPY
Non operating expensesPrior1YTDDuration130000000JPY
Non operating expensesCurrentYTDDuration154000000JPY
Ordinary incomePrior1YTDDuration7072000000JPY
Ordinary incomeCurrentYTDDuration7094000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration2000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration6000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass